A study suggests a new way to personalize anti-CTLA-4 therapy for cancers
The Ludwig Cancer Research study has identified a new mechanism by which a type of cancer immunotherapy called CTLA-4 can block immune cells to help destroy certain tumors. These tumors are largely…
